-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
January 01, 2011 - clinical
outcomes
• Patient outcomes of interest are:
– Mortality
– Morbidity (e.g., cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
September 01, 2012 - METHODS: We evaluated the treatment of patients with
high-risk (positive cardiac markers and/or ischemic … established in partnership working; the collaborative
approach to providing palliative care for end-stage cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
December 01, 2010 - Cardiac
resynchronization in patients with congestive
heart failure and chronic atrial fibrillation … Adults with with
dilated
cardiomyopathy and
intraventricular
conduction delay
Implanted permanent cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
February 01, 2016 - For opioids, we excluded the drug
propoxyphene, a weak analgesic associated with risk
of cardiac arrhythmia … a
serotonin norepinephrine reuptake inhibitor that is not
associated with the anticholinergic and cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
February 01, 2018 - agent therapy (statin
+ lipid modifying
medication) and
intensification of statin
therapy
Cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - specific information about general health and physiological measures of
skin, eye, gastrointestinal, cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_executive.pdf
August 01, 2016 - uncontrolled hypertension, preservation
or salvage of kidney function, prevention
or treatment of cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
March 01, 2013 - Cabergoline therapy
and the risk of cardiac valve regurgitation in patients with
hyperprolactinemia
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
January 01, 2015 - Preoperative statin
therapy for patients undergoing cardiac
surgery.
-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
November 03, 2020 - obstructive sleep apnea,xviii chronic
obstructive pulmonary disease (COPD), chronic
kidney disease,xix cardiac … function;
o obstructive sleep apnea
o ASA score
o chronic obstructive
pulmonary disease (COPD)
o cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
January 01, 2015 - described as submaximal.Page
111 Table 25 states that the number of patients
experiencing sudden cardiac … therefore leads one to conclude that no patients in the
groups listed in Table 25 died of sudden cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - donor lung supply, new
alternatives such as the use of lungs from older donors, lungs donated after cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
March 01, 2012 - disease, one would
have to define a composite outcome of death or myocardial infarction or other cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
January 01, 2014 - seeing
null results may be the type of populations studied; for
example, three TM trials enrolled cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
June 15, 2016 - ameliorate the complications posed by
obesity when it coexists with pathological
conditions such as cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - in phone
interview and 23%
reported using cc aspirin
Acute MI
requiring
admission or
sudden cardiac … : 0.86
(0.70, 1.04)
No dose-relationship;
increased risk for males
and for individuals with a
cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - ranges from $20,000 to
$35,000.54 The cost generally includes preoperative lab work, x-ray fees, cardiac … benefits would be realized only if these
therapies do not pose risk of serious adverse events (i.e., cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
May 29, 2025 - all"cause,$cardiovascular$disease"specific,$and$cerebrovascular$
disease"specific)$
o$ Morbidity$(cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research.pdf
April 01, 2025 - device identifier
demonstration project: Implementing point of
use product identification in the cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_surveillance.pdf
August 30, 2014 - diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia,
cardiomyopathies and cardiac